Parallel chiral sub/supercritical fluid chromatography screening as a framework for accelerated purification of pharmaceutical targets.

Chiral supercritical fluid chromatography Enantiomers purification Enantiopurity analysis Parallel column screening

Journal

Journal of chromatography. A
ISSN: 1873-3778
Titre abrégé: J Chromatogr A
Pays: Netherlands
ID NLM: 9318488

Informations de publication

Date de publication:
05 Jul 2022
Historique:
received: 15 03 2022
revised: 21 04 2022
accepted: 27 04 2022
pubmed: 25 5 2022
medline: 22 6 2022
entrez: 24 5 2022
Statut: ppublish

Résumé

Chiral sub/supercritical fluid chromatography (SFC) has established itself as one of the preferred techniques for enantioseparations at both analytical and preparative scale. Herein, we introduce a parallel multicolumn SFC screening for automated chiral method development in fast-paced settings. The practicality and speed advantages of this approach are illustrated with parallel screening of a diverse set of chiral molecules across ten columns with five different organic modifiers/CO

Identifiants

pubmed: 35609494
pii: S0021-9673(22)00287-4
doi: 10.1016/j.chroma.2022.463094
pii:
doi:

Substances chimiques

Indicators and Reagents 0
Pharmaceutical Preparations 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

463094

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Gioacchino Luca Losacco (GL)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, NJ 07065, United States of America.

Jimmy O DaSilva (JO)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, NJ 07065, United States of America. Electronic address: jimmy.dasilva@merck.com.

Imad A Haidar Ahmad (IA)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, NJ 07065, United States of America.

Ian Mangion (I)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, NJ 07065, United States of America.

Terry A Berger (TA)

SFC Solutions, Inc., Englewood, Florida 34224, United States of America.

Erik L Regalado (EL)

Analytical Research and Development, MRL, Merck & Co., Inc., 126 E. Lincoln Avenue, Rahway, NJ 07065, United States of America. Electronic address: erik.regalado@merck.com.

Articles similaires

Humans Pharmaceutical Preparations Drug Utilization Prescription Drugs
Risk Assessment Plant Leaves Isomerism Humans Stereoisomerism
Glutamine Stereoisomerism Spectrometry, Fluorescence Colorimetry Carbon
Ethiopia Humans Cross-Sectional Studies Qualitative Research Health Facilities

Classifications MeSH